Radiation Therapy Efficacy and Toxicity for Orbital and Ocular Adnexal Mucosa-Associated Lymphoid Tissue (OAMALT): A Single-Center, Retrospective Study of 32 Cases

References

• Gerbino G, Boffano P, Benech R, et al. Orbital lymphomas: clinical and radiological features. J Craniomaxillofac Surg. 2014;42(5):508–512. doi:10.1016/j.jcms.2013.07.01724051193
   PubMed Web of Science ®Google Scholar
• Ferry JA, Fung CY, Zuckerberg L, et al. Lymphoma of the ocular adnexa: a study of 353 cases. Am J Surg Pathol. 2007;31:170–184. doi:10.1097/01.pas.0000213350.49767.4617255761
   PubMed Web of Science ®Google Scholar
• Jenkins C, Rose GE, Bunce C, et al. Histological features of ocular adnexal lymphoma (REAL classification) and their association with patient morbidity and survival. Br J Ophthalmol. 2000;84:907–913. doi:10.1136/bjo.84.8.90710906102
   PubMed Web of Science ®Google Scholar
• Couland SE, Krause L, Delecluse HJ, et al. Lymphoproliferative lesions of the ocular adnexa. Analysis of 112 cases. Ophthalmology. 1998;105:1430–1441. doi:10.1016/S0161-6420(98)98024-19709754
   PubMed Web of Science ®Google Scholar
• Hsu CR, Chen YY, Yao M, Wei YH, Hsieh YT, Liao SL. Orbital and ocular adnexal lymphoma: a review of epidemiology and prognostic factors in Taiwan. Eye. 2020. PMID: 32994547. doi:10.1038/s41433-020-01198-y
   PubMed Web of Science ®Google Scholar
• Kharod SM, Herman MP, Morris CG, et al. Radiotherapy in the management of orbital lymphoma: a single institution’s experience over 4 decades. Am J Clin Oncol. 2018;41(1):100–106.26398063
   PubMed Web of Science ®Google Scholar
• Eckardt AM, Lemound J, Rana M, Gellrich NC. Orbital lymphoma: diagnostic approach and treatment outcome. World J Surg Onc. 2013;11:1–7.
   PubMed Web of Science ®Google Scholar
• Gveroviæ-Antunica A, Markoviæ I, Bohaè M, Coroviæ-Arneri E, Ivaniin-Baraè A, Karaman K. Primary orbital non-Hodgkin's lymphoma. case report. Acta Clin Croat. 2007;46:113–116.
   Google Scholar
• Cicco LD, Cella L, Liuzzi R, et al. Radiation therapy in primary orbital lymphoma: a single institution retrospective analysis. Radiat Oncol. 2009;4:1–6.19138400
   PubMed Web of Science ®Google Scholar
• Kiesewetter B, Lukas J, Kuchar A, et al. Clinical features, treatment and outcome of mucosa-associated lymphoid tissue (MALT) lymphoma of the ocular adnexa: single center experience of 60 patients. PLoS One. 2014;9:e104004. doi:10.1371/journal.pone.010400425077481
   PubMed Web of Science ®Google Scholar
• Rasmussen PK, Ralfkiaer E, Prause JU, et al. Follicular lymphoma of the ocular adnexal region: a nation-based study. Acta Ophthalmol. 2015;93:184–191. doi:10.1111/aos.1252525125069
   PubMed Web of Science ®Google Scholar
• Cohen V. Treatment options for ocular adnexal lymphoma (OAL). Clin Ophthalmol. 2009;3:689–692. doi:10.2147/OPTH.S582820054418
   PubMedGoogle Scholar
• Son SH, Choi BO, Kim GW, et al. Primary radiation therapy in patients with localized orbital marginal-zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT Lymphoma). Int J Radiat Oncol Biol Phys. 2010;77:86–91. doi:10.1016/j.ijrobp.2009.04.01819632068
   PubMed Web of Science ®Google Scholar
• Lowry L, Smith P, Qian W, et al. Reduced dose radiotherapy for local control in non-Hodgkin lymphoma: a randomised Phase III trial. Radiother Oncol. 2011;100(1):86–92. PMID: 21664710. doi:10.1016/j.radonc.2011.05.01321664710
   PubMed Web of Science ®Google Scholar
• Hoskin PJ, Kirkwood AA, Popova B, et al. 4 Gy versus 24 Gy radiotherapy for patients with indolent lymphoma (FORT): a randomised Phase 3 non-inferiority trial. Lancet Oncol. 2014;15(4):457–463. PMID: 24572077. doi:10.1016/S1470-2045(14)70036-124572077
   PubMed Web of Science ®Google Scholar
• Hoskin P, Popova B, Schofield O, et al. 4 Gy versus 24 Gy radiotherapy for follicular and marginal zone lymphoma (FoRT): long-term follow-up of a multicentre, randomised, phase 3, non-inferiority trial. Lancet Oncol. 2021;22(3):332–340. PMID: 33539729. doi:10.1016/S1470-2045(20)30686-033539729
   PubMed Web of Science ®Google Scholar
• Hashimoto N, Sasaki R, Nishimura H, et al. Long-term outcome and patterns of failure in primary ocular adnexal mucosa-associated lymphoid tissue lymphoma treated with radiotherapy. Int J Radiat Oncol Biol Phys. 2012;82:1509–1514. doi:10.1016/j.ijrobp.2011.04.05221664061
   PubMed Web of Science ®Google Scholar
• Bhatia S, Paulino AC, Buatti JM, et al. Curative radiotherapy for primary orbital lymphoma. Int J Radiat Oncol Biol Phys. 2002;54:818–823. doi:10.1016/S0360-3016(02)02966-812377334
   PubMed Web of Science ®Google Scholar
• Le QT, Eulau SM, George TI, et al. Primary radiotherapy for localized orbital MALT lymphoma. Int J Radiat Oncol Biol Phys. 2002;52:657–663. doi:10.1016/S0360-3016(01)02729-811849787
   PubMed Web of Science ®Google Scholar
• Uno T, Isobe K, Shikama N, et al. Radiotherapy for extranodal, marginal zone, B-cell lymphoma of mucosa-associated lymphoid tissue originating in the ocular adnexa: a multiinstitutional, retrospective review of 50 patients. Cancer. 2003;98:865–871. doi:10.1002/cncr.1153912910532
   PubMed Web of Science ®Google Scholar
• Fung CY, Tarbell NJ, Lucarelli MJ, et al. Ocular adnexal lymphoma: clinical behavior of distinct World Health Organization classification subtypes. Int J Radiat Oncol Biol Phys. 2003;57:1382–1391. doi:10.1016/S0360-3016(03)00767-314630277
   PubMed Web of Science ®Google Scholar
• Kennerdell JS, Flores NE, Hartsock RJ. Low-dose radiotherapy for lymphoid lesions of the orbit and ocular adnexa. Ophthal Plast Reconstr Surg. 1999;15:129–133. doi:10.1097/00002341-199903000-00012
   PubMed Web of Science ®Google Scholar
• Zhou P, Ng AK, Silver B, et al. Radiation therapy for orbital lymphoma. Int J Radiat Oncol Biol Phys. 2005;63:866–871. doi:10.1016/j.ijrobp.2005.03.00515925453
   PubMed Web of Science ®Google Scholar
• Fitzpatrick PJ, Macko S. Lymphoreticular tumors of the orbit. Int J Radiat Oncol Biol Phys. 1984;10(3):333–340. PMID: 6368493. doi:10.1016/0360-3016(84)90051-86368493
   PubMed Web of Science ®Google Scholar
• Bolek TW, Moyses HM, Marcus RB, et al. Radiotherapy in the management of orbital lymphoma. Int J Radiat Oncol Biol Phys. 1999;44(1):31–36. PMID: 10219791. doi:10.1016/s0360-3016(98)00535-510219791
   PubMed Web of Science ®Google Scholar
• Stafford SL, Kozelsky TF, Garrity JA, et al. Orbital lymphoma: radiotherapy outcome and complications. Radiother Oncol. 2001;59(2):139–144. PMID: 11325441. doi:10.1016/s0167-8140(00)00328-511325441
   PubMed Web of Science ®Google Scholar
• Parikh RR, Moskowitz BK, Maher E, et al. Long-term outcomes and patterns of failure in orbital lymphoma treated with primary radiotherapy. Leuk Lymphoma. 2015;56(5):1266–1270. PMID: 25356924. doi:10.3109/10428194.2014.97941525356924
   PubMed Web of Science ®Google Scholar
• Martinet S, Ozsahin M, Belkacémi Y, et al. Outcome and prognostic factors in orbital lymphoma: a Rare Cancer Network study on 90 consecutive patients treated with radiotherapy. Int J Radiat Oncol Biol Phys. 2003;55(4):892–898. PMID: 12605966. doi:10.1016/s0360-3016(02)04159-712605966
   PubMed Web of Science ®Google Scholar